Sign inJoin waitlistJoin the waitlist

Debanjan Pain

Assistant Professor, Health Services Research · University of Texas M D Anderson Cancer Center

Credentials: · · · ·

History

University of Texas M D Anderson Cancer Center
Present
University of Pennsylvania Health System · Perelman School of Medicine at the University of Pennsylvania
Present
University of Pennsylvania Health System
Present

Hematology and Medical Oncology
University of Pennsylvania
2021–2024
Internal Medicine
Beth Israel Deaconess Medical Center
2018–2019
Johns Hopkins Univ Sch of Med
2014–2018

Research

Measuring pediatric hospital readmission rates to drive quality improvement
Academic Pediatrics · 2014 · 61 citations
Access to and Affordability of World Health Organization Essential Medicines for Cancer in Sub-Saharan Africa: Examples from Kenya, Rwanda, and Uganda
The Oncologist · 2022 · 36 citations
Barriers to Implementing a Quality Improvement Program in Low- and Middle-Income Countries: Adequacy of Resources
Review · JCO Global Oncology · 2024 · First of 10 authors · 19 citations

Ana Aparicio
2 papers
Lawrence Shulman
2 papers
Megan Kassick
2 papers · 2 as a resident
Surbhi Grover
2 papers
Yehoda Martei
2 papers
Alexandra Geanacopoulos
1 paper
Andrew Hahn
1 paper
AG
Arun Goel
1 paper
AJ
Ashish Jha
1 paper
BD
Barbara Dietrick
1 paper · 1 as a resident
BA
Bethel Adefres
1 paper · 1 as a resident
BS
Bilal Siddiqui
1 paper

Clinical trials

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer
Principal investigator · Not yet recruiting
M.D. Anderson Cancer Center
2026–2030
Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital
Principal investigator · Recruiting
M.D. Anderson Cancer Center
2026–2030
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Site PI · Recruiting · Phase 2, Phase 3
National Cancer Institute (NCI)
2024–2030